All In Biotech

Free tool

FAERS Monitor: Fragmin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020287 or its brand name (Fragmin, Dalteparin Sodium). Reports on generic versions are filed under their own applications.

Reports

10,659

Serious

9,759

92% of reports

Hospitalization

5,540

Death reported

2,313

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • nausea720
  • off label use714
  • pulmonary embolism618
  • dyspnoea603
  • vomiting586
  • abdominal pain537
  • sepsis513
  • pyrexia501
  • general physical health deterioration477
  • diarrhoea461
  • fatigue461
  • anaemia458
  • constipation457
  • death422
  • condition aggravated418

Reports by year received

View as table
YearReports
2004192
2005182
2006205
2007233
2008219
2009339
2010399
2011505
2012572
2013390
2014442
2015477
2016522
2017472
2018607
2019641
2020640
2021859
2022710
2023667
2024542
2025446
2026396

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,500 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pulmonary embolismSignal61812.912.06,765
sepsisSignal5139.18.43,700
general physical health deteriorationSignal4778.27.52,996
anaemiaSignal4584.74.31,360
abdominal painSignal5374.64.21,504
constipationSignal4574.13.81,095
pyrexiaSignal5012.92.6613
condition aggravatedSignal4182.72.5457
vomitingSignal5862.52.3518
dyspnoeaSignal6032.11.9357
nausea7201.81.7263
off label use7141.61.5171
diarrhoea4611.41.356
fatigue4611.21.111
death4221.00.90

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.